Used in pharmaceutical research as a key intermediate for synthesizing protease inhibitors, particularly in the development of drugs targeting neurodegenerative diseases. Its boronic acid group enables reversible binding to enzyme active sites, enhancing inhibitory activity. Also employed in Suzuki-Miyaura cross-coupling reactions for constructing biaryl compounds in medicinal chemistry. Shows potential in radiolabeling studies due to fluorine-18 compatibility for PET imaging applications.